Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VC005 in Non-segmental Vitiligo
NCT07172347Phase 2Recruiting
- Sponsor
- Jiangsu Vcare PharmaTech Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VC-005 in Vitiligo, sponsored by Jiangsu Vcare PharmaTech Co., Ltd.. Started Oct 2025; status: recruiting.
02
Drugs
VC-005
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07172347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07172347.